TLK199: Phase I/IIA testing update

Telik Inc. (TELK), South San Francisco, Calif. Product: TLK199 Business: Cancer Therapeutic category: Enzyme inhibitor Target: Glutathione-S-transferase P1-1 enzyme ( GST P1-1) Description: Small mo...